Home/ Stocks/ OABI

OmniAb, Inc. Common Stock

OABI XNAS

$1.66 +0.15 (+9.87%) ▲ 15-min delayed

Open

$1.54

High

$1.69

Low

$1.52

Volume

5.66M

Market Cap

$240.65M

About OmniAb, Inc. Common Stock

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Sector: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH Employees: 89 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$18.67M	$-64,779,000	$-0.57
FY 2025	$18.67M	$-64,779,000	$-0.57
Q3 2025	$2.24M	$-16,525,000	$-0.14
Q2 2025	$3.90M	$-15,875,000	$-0.15

Earnings & Analyst Ratings

Next Earnings: Tue, Aug 4, 2026

Calendar →

Related Market News

No specific coverage for OABI yet. Check out our latest market news or earnings calendar.

Get OABI Alerts

Stay ahead with breaking news, price alerts, and expert analysis on OmniAb, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.